• Home
  • About Us
  • Information updates
  • ASCIA website update – new documents about how to introduce solid foods for allergy prevention (FAQ) and oral immunotherapy (OIT) for food allergy

Information updates

ASCIA website update – new documents about how to introduce solid foods for allergy prevention (FAQ) and oral immunotherapy (OIT) for food allergy

2 May 2018

The following two new ASCIA documents for parents, patients, carers and consumers are now available on the ASCIA website:

  • How to introduce solid foods for allergy prevention - in a new frequently asked questions (FAQ) format
  • Oral immunotherapy (OIT) for food allergy 
How to introduce solid foods for allergy prevention FAQ

This document provides updated practical advice in a more user-friendly FAQ format, about how to introduce solid foods to babies, based on currently available evidence for food allergy prevention. It is relevant for all babies, including babies with severe eczema, existing food allergy or a family member with allergies and is available open access on the ASCIA website: www.allergy.org.au/patients/allergy-prevention/ascia-how-to-introduce-solid-foods-to-babies

The previous version of this document was recently accessed or downloaded from the ASCIA website around 5,000 times per month, so we expect this more user-friendly version will be even more popular! 

New information on oral immunotherapy (OIT) for food allergy

Information about OIT, a potential treatment for food allergy, is now available open access on the ASCIA website: www.allergy.org.au/patients/allergy-treatment/oral-immunotherapy-for-food-allergy 

OIT involves administering gradually increasing amounts of food allergen under medical supervision. However, OIT methods for treating food allergy are not currently standardised or approved for routine treatment in the USA or globally. There are concerns about a high (or unknown) risk of potential harm in patients with severe food allergy, as well as considerable cost implications. Trials on OIT for food allergy are currently underway in Australia and other countries, that aim to develop standardised and proven methods, to maximise benefit and reduce the risk of potential harm in patients with severe food allergy.

 

Content created 2 May 2018

Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information.Verify here.